Varenicline's mechanism of action involves which partial agonist activity?

• A. Partial agonist at the alpha4beta2 nicotinic receptor
• B. Full agonist at the GABA receptors
• C. Monoamine oxidase inhibition
• D. Dopamine receptor antagonist

Answer: (A)

Varenicline works because it acts as a partial agonist at the alpha4beta2 nicotinic acetylcholine receptors in the brain. Activation of these receptors by nicotine drives dopamine release in the mesolimbic pathway, reinforcing smoking. By providing only partial stimulation, varenicline helps reduce withdrawal and cravings while occupying the receptor enough to blunt the full dopamine boost if someone smokes. This dual action lowers both the urge to smoke and the pleasure from smoking.

The other options don’t fit: varenicline does not act as a full agonist on GABA receptors, does not inhibit monoamine oxidase, and does not antagonize dopamine receptors. Its beneficial effect comes from this selective partial activation of alpha4beta2 nicotinic receptors.